Mauna Kea Technologies SAS (MKT), is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides a confocal laser endomicroscopy platform. MKT’s Cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics studies, longitudinal monitoring of disease progression and in vivo histology. It provides technical support and training. MKT’s products are used for treatment of digestive diseases chronic acid reflux, pancreatic cysts, gastric disease and diagnosing respiratory diseases and also used in laboratories for research on small animals. The company has presence in North America, Europe and Asia. MKT is headquartered in Paris, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Mauna Kea Technologies SAS
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Mauna Kea Technologies SAS Company Overview
- Mauna Kea Technologies SAS Company Snapshot
- Mauna Kea Technologies SAS Pipeline Products and Ongoing Clinical Trials Overview
- Mauna Kea Technologies SAS - Pipeline Analysis Overview
- Mauna Kea Technologies SAS - Key Facts
- Mauna Kea Technologies SAS - Major Products and Services
- Mauna Kea Technologies SAS Pipeline Products by Development Stage
- Mauna Kea Technologies SAS Pipeline Products Overview
- Cellvizio - COVID-19
- Cellvizio - COVID-19 Product Overview
- Cellvizio - Food Allergy
- Cellvizio - Food Allergy Product Overview
- NIR-nCLE System
- NIR-nCLE System Product Overview
- Mauna Kea Technologies SAS - Key Competitors
- Mauna Kea Technologies SAS - Key Employees
- Mauna Kea Technologies SAS - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Mauna Kea Technologies SAS, Recent Developments
- Jan 27, 2025: Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio for Precision Surgery in Head and Neck Cancers
- Nov 20, 2024: Mauna Kea Technologies Celebrates Over 700 Procedures Performed in 18 Months at IECED-OMNI Hospital in Ecuador
- Nov 13, 2024: Mauna Kea Technologies Provides an Update on Its Recent Developments
- Oct 17, 2024: Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance
- Sep 16, 2024: Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio
- Sep 10, 2024: Mauna Kea Technologies Announces Endorsement from The American Foregut Society for Payor Policy Coverage of Cellvizio
- Jun 26, 2024: Mauna Kea Technologies Unveils Celltolerance, a Subsidiary Dedicated to Its Unique Program for the Detection and Treatment of Food Intolerances
- May 06, 2024: Mauna Kea Technologies Announces 9 Presentations Demonstrating the Clinical Value of Cellvizio at Digestive Disease Week 2024
- Apr 02, 2024: Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio to Identify and Treat Food Intolerance in Adults
- Mar 27, 2024: Mauna Kea Technologies Partners with V7 To Develop Innovative AI Applications With Cellvizio
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Mauna Kea Technologies SAS Pipeline Products and Ongoing Clinical Trials Overview
- Mauna Kea Technologies SAS Pipeline Products by Equipment Type
- Mauna Kea Technologies SAS Pipeline Products by Indication
- Mauna Kea Technologies SAS, Key Facts
- Mauna Kea Technologies SAS, Major Products and Services
- Mauna Kea Technologies SAS Number of Pipeline Products by Development Stage
- Mauna Kea Technologies SAS Pipeline Products Summary by Development Stage
- Cellvizio - COVID-19 - Product Status
- Cellvizio - COVID-19 - Product Description
- Cellvizio - Food Allergy - Product Status
- Cellvizio - Food Allergy - Product Description
- NIR-nCLE System - Product Status
- NIR-nCLE System - Product Description
- Mauna Kea Technologies SAS, Key Employees
- Mauna Kea Technologies SAS, Subsidiaries
- Glossary
- Mauna Kea Technologies SAS Pipeline Products by Equipment Type
- Mauna Kea Technologies SAS Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Surgical Innovations Group Plc
- Zimmer Biomet Robotics
- Theraclion SA
- SuperSonic Imagine SA
- Carmat SAS
- Median Technologies SA
